BMI与肥胖对肺动脉高压患者生存的影响
基于法国肺动脉高压网络登记库中1255例特发性、药物诱发性和遗传性肺动脉高压患者的研究,评估BMI与肥胖同全因死亡的关系。多变量分析显示BMI和肥胖整体与死亡率无关,但年龄与肥胖存在交互作用,<65岁病态肥胖患者死亡风险升高(HR 3.01, 95%CI 1.56-5.79, P=.001)。
要点
- 肥胖在PAH患者中常见(30%),但整体BMI和肥胖与全因死亡率无显著关联。
- <65岁病态肥胖患者死亡风险显著增加(HR 3.01, 95%CI 1.56-5.79, P=.001)。
- 年轻病态肥胖的PAH患者若为肺移植候选者,应积极管理体重。
核心结论
- 整体人群中肥胖与死亡率无关,但年龄与肥胖存在交互作用,年轻病态肥胖患者死亡风险增加。
研究设计与样本
- 基于法国肺动脉高压网络登记库的队列研究,纳入1255例新发特发性、药物诱发性和遗传性PAH患者。
- 采用Cox回归和Kaplan-Meier分析评估BMI和肥胖与全因死亡率的关联。
主要发现
- 肥胖组女性比例更高(65.1% vs 53.4%,P<.01),药物诱发PAH比例更高(28.9% vs 9.2%,P<.01)。
- 肥胖组NYHA III级比例更高(66.4% vs 57.1%),IV级比例更低(11.8% vs 16.9%,P<.01),6分钟步行距离更低(276±121 vs 324±146,P<.01)。
- 肥胖组右房压、肺楔压和心脏指数更高,肺血管阻力更低。
- 多变量分析中BMI(HR 0.99, 95%CI 0.97-1.01, P=.41)和肥胖(HR 1.0, 95%CI 0.99-1.01, P=.46)与死亡率无显著关联。
- <65岁病态肥胖患者死亡风险增加(HR 3.01, 95%CI 1.56-5.79, P=.001)。
临床怎么用
- 对PAH患者评估预后时不应仅凭肥胖判断死亡风险,整体肥胖不增加死亡率。
- 对<65岁病态肥胖的PAH患者,尤其是肺移植候选者,应积极进行体重管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: An obesity paradox, wherein patients who are obese have lower mortality, has been described in cardiopulmonary diseases, including pulmonary arterial hypertension (PAH). Our objective was to determine whether obesity and BMI are associated with mortality in patients with PAH. METHODS: We assessed incident patients with idiopathic, drug-induced, and heritable PAH from the French Pulmonary Hypertension Network registry. Cox regression and Kaplan-Meier analysis were used to assess the association between BMI and obesity with all-cause mortality. RESULTS: Of 1,255 patients included, 30% were obese. A higher proportion of women (65.1% vs 53.4%, P < .01), drug-induced PAH (28.9% vs 9.2%, P < .01), systemic hypertension, diabetes, and hypothyroidism were present in the obese group. More obese patients were in New York Heart Association class III (66.4% vs 57.1%), fewer were class IV (11.8% vs 16.9%, P < .01), and 6-min walk distance was lower (276 ± 121 vs 324 ± 146, P < .01). Right atrial pressure, pulmonary wedge pressure, and cardiac index were higher, whereas pulmonary vascular resistance was lower in patients who were obese. Neither BMI (hazard ratio [HR], 0.99; 95% CI, 0.97-1.01; P = .41) nor obesity (HR, 1.0; 95% CI, 0.99-1.01; P = .46) were associated with mortality in multivariable analyses. There was a significant interaction between age and obesity such that mortality increased among patients < 65 years of age who were morbidly obese (HR, 3.01; 95% CI, 1.56-5.79; P = .001). CONCLUSIONS: Obesity was not associated with mortality in the overall population, but there was an age-obesity interaction with increased mortality among young patients who were morbidly obese. These results have implications for active weight management in younger patients who are morbidly obese who are otherwise candidates for lung transplantation.
引用
- Weatherald J, Huertas A, Boucly A, et al. Association Between BMI and Obesity With Survival in Pulmonary Arterial Hypertension. Chest. 2018. PMID: 29800550. doi:10.1016/j.chest.2018.05.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。